Outcome of Nivolumab-Induced Vogt–Koyanagi–Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy

Figure 2

Images of treatment progress on optical coherence tomography. The left column shows images of the right eye, and the right column shows images of the left eye. The patient’s decimal BCVA on the same day was obtained. (a, b) Before treatment, both eyes had SRD, wavy RPE, and choroidal thickening. (c, d) After 1 week, the volume of subretinal fluid decreased. Only the right eye received subtenon injection of triamcinolone acetonide. Both eyes had similar improvements in abnormal findings. (e, f) After 1 month, SRD and wavy RPE disappeared. At this point, the maximum visual acuity was achieved before cataract surgery. (g, h) After 6 months and a half, the patient was in remission. Choroidal thinning had become more prominent. (i, j) After approximately 1 year, the patient remained in remission.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)